Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03544281
What this trial is testing

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 153
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Not applicableLooking for participantsNCT07528365
What this trial is testing

Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid Restriction

Who this might be right for
SIAD - Syndrome of Inappropriate Antidiuresis
University of Turin, Italy 20
Early research (Phase 1)Study completedNCT02116465
What this trial is testing

Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration

Who this might be right for
Fasted State
Desitin Arzneimittel GmbH 12
Testing effectiveness (Phase 2)Ended earlyNCT00985907
What this trial is testing

Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPatient Participation
University of California, San Francisco 13
Testing effectiveness (Phase 2)Study completedNCT00975975
What this trial is testing

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more
Indiana University 17
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Study completedNCT01913730
What this trial is testing

Maintenance Therapy With Subcutaneous Bortezomib

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 63
Not applicableStudy completedNCT02396290
What this trial is testing

Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar

Who this might be right for
Acne Scar
Seoul National University Hospital 29
Large-scale testing (Phase 3)Study completedNCT00200681
What this trial is testing

IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 493
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Early research (Phase 1)UnknownNCT05005884
What this trial is testing

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 80
Early research (Phase 1)UnknownNCT04706936
What this trial is testing

Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Not applicableStudy completedNCT02849444
What this trial is testing

Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance

Who this might be right for
Multiple Myeloma
Celgene 326
Testing effectiveness (Phase 2)Looking for participantsNCT05979363
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT00000914
What this trial is testing

The Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 800
Not applicableUnknownNCT03907306
What this trial is testing

Cold Argon Plasma (CAP) Application in the Wound Treatment After Open Hemorrhoidectomy

Who this might be right for
Cold Argon Plasma
State Scientific Centre of Coloproctology, Russian Federation 100
Very early researchStudy completedNCT04458363
What this trial is testing

Convalescent Plasma in Pediatric COVID-19

Who this might be right for
COVID
Emory University 3
Not applicableStudy completedNCT03956615
What this trial is testing

SdAb-based TRNT of Multiple Myeloma: a Feasibility Study

Who this might be right for
Multiple Myeloma
Universitair Ziekenhuis Brussel 10
Not applicableLooking for participantsNCT05726825
What this trial is testing

Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock

Who this might be right for
Septic Shock
Hannover Medical School 274
Next Page